CareBridge Automations strengthens 340B compliance readiness, guides mission-aligned reinvestment, and documents community impact for covered entities nationwide.
We provide advisory, enablement, and documentation support—without participating in drug purchasing, billing, or attestations. This clear boundary ensures compliance integrity while delivering expert guidance.

To empower covered entities with the knowledge, frameworks, and documentation needed to participate in the 340B Drug Pricing Program with confidence, compliance, and maximum community benefit—while maintaining the highest standards of regulatory integrity.
These principles guide every engagement, recommendation, and deliverable we provide to covered entities.
We maintain strict ethical boundaries, never purchasing drugs, managing billing, or signing attestations. Our advisory role ensures your organization retains full control and accountability.
Every recommendation we make serves your organization's safety-net mission and community health priorities, ensuring 340B savings create maximum impact.
Our frameworks and documentation standards anticipate HRSA scrutiny, building defensible compliance infrastructure that withstands regulatory review.
We work alongside your team as trusted advisors, building internal capacity and knowledge rather than creating dependency on external consultants.
The 340B Drug Pricing Program allows eligible covered entities to purchase outpatient drugs at significantly reduced prices, enabling reinvestment in patient care and community health services.
Participation in 340B requires strict adherence to federal regulations administered by the Health Resources and Services Administration (HRSA). Covered entities must: